Global X HealthTech ETF (NASDAQ:HEAL) Sees Large Decline in Short Interest

Posted by Paula Ricardo on Jul 14th, 2026

Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a significant decline in short interest in June. As of June 30th, there was short interest totaling 13,534 shares, a decline of 64.0% from the June 15th total of 37,633 shares. Approximately 1.3% of the company’s stock are short sold. Based on an average daily volume of 8,169 shares, the short-interest ratio is presently 1.7 days.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Daiwa Securities Group Inc. purchased a new stake in Global X HealthTech ETF during the 3rd quarter valued at approximately $11,239,000. WT Wealth Management boosted its holdings in Global X HealthTech ETF by 14.7% in the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock valued at $2,409,000 after purchasing an additional 12,945 shares in the last quarter. Flow Traders U.S. LLC acquired a new position in Global X HealthTech ETF during the 3rd quarter worth approximately $368,000. Raymond James Financial Inc. acquired a new position in Global X HealthTech ETF during the 3rd quarter worth approximately $274,000. Finally, Citadel Advisors LLC purchased a new position in shares of Global X HealthTech ETF during the 3rd quarter worth approximately $216,000.

Global X HealthTech ETF Stock Down 1.5%

Global X HealthTech ETF stock traded down $0.42 during mid-day trading on Tuesday, reaching $28.07. 5,634 shares of the company’s stock were exchanged, compared to its average volume of 11,094. The company has a market cap of $29.75 million, a P/E ratio of 42.80 and a beta of 1.10. Global X HealthTech ETF has a twelve month low of $23.00 and a twelve month high of $33.59. The company has a fifty day moving average of $26.08 and a 200-day moving average of $26.59.

About Global X HealthTech ETF

(Get Free Report)

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.